6,363 results on '"International Business Machines Corp. -- Product development"'
Search Results
2. International Business Machines Corporation (IBM) Reports Findings in Boltzmann Machines (Solving Max-Cut Problem Using Spiking Boltzmann Machine Based on Neuromorphic Hardware with Phase Change Memory)
3. Abcuro Completed Enrollment of Registrational Phase 2|3 MUSCLE Clinical Trial of Ulviprubart for the Treatment of Inclusion Body Myositis
4. Abcuro Completes Enrollment of Registrational Phase 2/3 MUSCLE Clinical Trial of Ulviprubart for the Treatment of Inclusion Body Myositis
5. Effect of cognitive - behavioral play therapy on working memory, short-term memory and sustained attention among school-aged children with specific learning disorder: a preliminary randomized controlled clinical trial
6. Abcuro Initiates Part B of Registrational Phase 2|3 MUSCLE Clinical Trial of Ulviprubart (ABC008) for the Treatment of Inclusion Body Myositis
7. Abcuro Initiates Part B of Registrational Phase 2/3 MUSCLE Clinical Trial of Ulviprubart (ABC008) for the Treatment of Inclusion Body Myositis
8. Siemens and IBM collaborate to accelerate sustainable product development and operations
9. United States : Siemens and IBM collaborate to accelerate sustainable product development and operations
10. Siemens and IBM collaborate to accelerate sustainable product development and operations
11. Siemens and IBM collaborate to accelerate sustainable product development and operations
12. Abcuro Initiated Registrational Phase 2|3 Study of ABC008 for the Treatment of Inclusion Body Myositis
13. Abcuro Initiates Registrational Phase 2/3 Study of ABC008 for the Treatment of Inclusion Body Myositis
14. New Data from University of North Carolina Illuminate Findings in Clinical Trials and Studies [A Randomized Trial Comparing Continence Pessary To Continence Device (Poise Impressa ®) for Stress Incontinence]
15. Abcuro Initiates Registrational Phase 2/3 Study of ABC008 for the Treatment of Inclusion Body Myositis
16. Abcuro Initiates Phase 1/2 Trial Evaluating ABC008 in Patients with T Cell Large Granular Lymphocytic Leukemia
17. Inclusion Body Myositis (IBM) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
18. Inclusion Body Myositis (IBM) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
19. Valued to be $3.9 Billion by 2026, Phase Change Memory Slated for Robust Growth Worldwide
20. Global Phase Change Memory Market to Reach $4 Billion by 2026
21. Health Quest to boost participation in clinical trials with IBM Watson
22. McCormick & Co. teams up with IBM in AI-enabled product development
23. IBM says new ultradense microchip might one day quadruple your cellphone's battery life
24. Abcuro to Presented Late-Breaking Abstract at American College of Rheumatology Convergence 2021 of ABC008 Inclusion Body Myositis Phase 1 Data Demonstrating Proof of Mechanism for Selective Depletion of Highly Cytotoxic T Cells
25. Abcuro to Present Late-Breaking Abstract at American College of Rheumatology Convergence 2021 of ABC008 Inclusion Body Myositis Phase 1 Data Demonstrating Proof of Mechanism for Selective Depletion of Highly Cytotoxic T Cells
26. Monopar Announces First Patient Dose in Camsirubicin Phase 1b Trial for Advanced Soft Tissue Sarcoma
27. Abcuro to Present Trial in Progress Poster on a Phase 1 Clinical Trial of ABC008 Demonstrating Targeted Depletion of Large Granular Lymphocytes at the 2021 Leukemia, Lymphoma and Myeloma Congress
28. WATSON LEARNS TO DEBATE: IBM Watson is a computer system that can answer questions posed to it in natural language. It might be most famous for its defeat of the two Jeopardy! champions in 2011, but the number of Watson's commercial applications from 2013 has grown into a division (IBM Watson products and solutions) at the company
29. Airtel and IBM complete first phase of Open Hybrid Cloud Network
30. Jazz and the eclipse way of collaboration
31. Patterning the world
32. Sanofi-backed Abcuro bags $42M to trial KLRG1 immunotherapy
33. Sanofi-backed Abcuro bags $42M to trial KLRG1 immunotherapy
34. The Open Market Woos Open Source
35. Pinnacle: IBM MXT in a Memory Controller Chip
36. SEMM-2: a new generation of single-event-effect modeling tools
37. The ultimate dielectric is... nothing: IBM packs wires in vacuum to speed chips and save power
38. Airtel and IBM complete first phase of Open Hybrid Cloud Network
39. IBM and AMD Announce Joint Development Agreement to Advance Confidential Computing for the Cloud and Accelerate Artificial Intelligence
40. United States : IBM and AMD Announce Joint Development Agreement to Advance Confidential Computing for the Cloud and Accelerate Artificial Intelligence
41. Biorasi selects IBM to expand clinical trial execution capabilities
42. Mateon is Selected by IBM Watson Health for the Use of IBM Clinical Development Solution at No Cost for Phase II Clinical Trial of OT-101 for COVID-19
43. MATEON IS SELECTED BY IBM WATSON HEALTH FOR THE USE OF IBM CLINICAL DEVELOPMENT SOLUTION AT NO COST FOR PHASE II CLINICAL TRIAL OF OT-101 FOR COVID-19
44. Mateon is Selected by IBM Watson Health for the Use of IBM Clinical Development Solution at No Cost for Phase II Clinical Trial of OT-101 for COVID-19
45. IBM Watson Health rolls out new clinical trial design software
46. IBM Study Advance Designed to Reduce the Time and Costs Associated with Clinical Trials
47. IBM Study Advance Designed to Reduce the Time and Costs Associated with Clinical Trials
48. IBM Study Advance Tool Aims to Reduce Cost and Time of Clinical Trials
49. IBM Study Advance Designed to Reduce the Time and Costs Associated with Clinical Trials
50. IBM Highlights Ballistic Nanowire Connections
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.